<DOC>
	<DOCNO>NCT01362699</DOCNO>
	<brief_summary>The purpose study ass whether JNJ-31001074 take 7 day reduces urge drink alcohol alcohol-dependent study participant seek treatment .</brief_summary>
	<brief_title>Effect JNJ 31001074 Urge Drink Alcohol-Dependent Adults</brief_title>
	<detailed_description>This study evaluate whether JNJ 31001074 reduces urge drink alcohol non treatment seek , adult study participant current alcohol dependence . Individuals meet criterion study participation randomly assign one two treatment group ( tablet contain JNJ 31001074 placebo tablet active ingredient ) 1:1 ratio . Treatment group assignment know study participant study staff . Baseline assessment record participant return clinic test last day take assign study medication 7 day home . Alcohol use allow 3 day prior end-of-dosing testing . During test , urge drink alcohol mood measure view various computer image present ( drink ) either favorite alcoholic beverage water . Other measure collect study evaluate safety tolerability study medication , include potential effect sleep , well measure think cigarette smoking . Participants return follow-up visit approximately 1 week finishing study medication complete clinic assessment . Study participant take one 3-mg tablet JNJ-31001074 matching placebo morning , preferably food , 7 day .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>Male female Currently alcohol dependent seek treatment Meets study criterion amount alcohol consume Otherwise healthy Urge drink increase presence alcohol Able complete understand questionnaire study procedure English Willing able comply study requirement , include 3day period alcohol abstinence use highly effective contraceptive method Signed informed consent . Pregnant breastfeeding Significant medical psychiatric condition alcohol dependence History , risk , medically significant alcohol withdrawal syndrome Dependent substance alcohol , nicotine caffeine Smokes 1 pack cigarette per day consume 500 mg caffeine per day Has glaucoma , cataract , history eye inflammation , eye injury , eye surgery correct vision Treatment past 1 month prior screen disulfiram ( Antabuse ) , acamprosate ( Campral ) , naltrexone ( ReVia Vivitrol ) , topiramate ( Topamax ) In need currently take psychoactive medication</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>62 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Alcoholism</keyword>
	<keyword>Alcohol-Related Disorders</keyword>
	<keyword>Substance-Related Disorders</keyword>
	<keyword>Mental Disorders</keyword>
	<keyword>Alcohol Dependence</keyword>
	<keyword>JNJ-31001074</keyword>
	<keyword>Bavisant</keyword>
</DOC>